Table 1. Survival of mice immunized or infected with CVS-F3 prior to infection with CVS-N2c.
Initial Infection or Immunization | Secondary Infection (Delay in Days) | Survival (Percent) |
None | CVS-N2c | 0/5 (0) |
CVS-F3, live | none | 5/5 (100) |
CVS-F3, live | CVS-N2 c (3) | 4/5 (80) |
CVS-F3, live | CVS-N2c (5) | 5/5 (100) |
CVS-F3, inactivated | CVS-N2c (3) | 0/5 (0) |
CVS-F3, inactivated | CVS-N2c (5) | 0/5 (0) |
CVS-F3, inactivated | CVS-N2c (21) | 10/10 (100) |
CVS-F3, live and inactivated | CVS-N2c (3) | 3/5 (60) |
CVS-F3, live and inactivated | CVS-N2c (5) | 5/5 (100) |